ZA822703B - Procedure for producing a vasal fibrinolytic active principle plus the enzymatic products so prepared - Google Patents

Procedure for producing a vasal fibrinolytic active principle plus the enzymatic products so prepared

Info

Publication number
ZA822703B
ZA822703B ZA822703A ZA822703A ZA822703B ZA 822703 B ZA822703 B ZA 822703B ZA 822703 A ZA822703 A ZA 822703A ZA 822703 A ZA822703 A ZA 822703A ZA 822703 B ZA822703 B ZA 822703B
Authority
ZA
South Africa
Prior art keywords
active principle
procedure
prepared
producing
enzymatic products
Prior art date
Application number
ZA822703A
Other languages
English (en)
Inventor
Gaetano Comi
Maurizio Pandolfi
Original Assignee
Manetti & Roberts Italo Brit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manetti & Roberts Italo Brit filed Critical Manetti & Roberts Italo Brit
Publication of ZA822703B publication Critical patent/ZA822703B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA822703A 1981-04-23 1982-04-21 Procedure for producing a vasal fibrinolytic active principle plus the enzymatic products so prepared ZA822703B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48332/81A IT1170913B (it) 1981-04-23 1981-04-23 Procedimento per la produzione di un principio attivo fibrinolitico vasale prodotto enzimatico specifico angiochinasi cosi' ottenuto e sue applicazioni farmaceutiche

Publications (1)

Publication Number Publication Date
ZA822703B true ZA822703B (en) 1983-03-30

Family

ID=11265948

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA822703A ZA822703B (en) 1981-04-23 1982-04-21 Procedure for producing a vasal fibrinolytic active principle plus the enzymatic products so prepared

Country Status (16)

Country Link
US (2) US4471053A (no)
EP (1) EP0064036B1 (no)
JP (1) JPS57181019A (no)
AT (1) ATE15071T1 (no)
AU (1) AU548758B2 (no)
CA (1) CA1184138A (no)
DE (1) DE3265559D1 (no)
DK (1) DK180682A (no)
ES (1) ES511604A0 (no)
IE (1) IE53107B1 (no)
IL (1) IL65448A (no)
IT (1) IT1170913B (no)
NO (1) NO821287L (no)
NZ (1) NZ200254A (no)
PT (1) PT74743B (no)
ZA (1) ZA822703B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA831399B (en) * 1982-03-05 1984-02-29 Health Lab Service Board New fibrinolytic enzymes and methods for their production and pharmaceutical compositions containing them
JPS58189122A (ja) * 1982-04-30 1983-11-04 Kaken Pharmaceut Co Ltd 高脂血症予防治療剤
JPS61112018A (ja) * 1984-11-06 1986-05-30 Mitsubishi Chem Ind Ltd 線溶増強剤
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US5275812A (en) * 1985-06-07 1994-01-04 The General Hospital Corporation Method of treatment for myocardial infarction
US5248688A (en) * 1986-09-10 1993-09-28 Dudrick Medical Research Fund I, Ltd. Method and substrate composition for treating atherosclerosis
US5032608A (en) * 1986-09-10 1991-07-16 Dudrick Stanley J Method and substrate composition for treating atherosclerosis
HU209955B (en) * 1987-07-01 1994-12-28 Genentech Inc Process for producing pharmaceutical compositions containing tissue- -plasminogen-activator of poor solubility for inhibiting production and regeneration of deformities
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
US5449679A (en) * 1994-07-29 1995-09-12 Leonard; Robert J. Process and products for reducing biological fluid levels of a lipid soluble waste
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
WO1999066797A1 (en) 1998-06-22 1999-12-29 Worden Charles E Enriched platelet wound healant
WO2006102488A1 (en) * 2005-03-22 2006-09-28 Cascade Medical Enterprises, Llc Systems and methods of producing membranes
DE102015010436B4 (de) * 2015-08-14 2019-01-24 Airbus Defence and Space GmbH Wabenkern für dimensionsstabile Sandwichbauteile, dessen Verwendung, Sandwichplatte mit diesem Wabenkern und Verfahren zur Herstellung des Wabenkerns

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998847A (en) * 1972-10-25 1976-12-21 Schering Aktiengesellschaft 9,10-secoestrane derivatives and their production
US3998947A (en) * 1973-11-30 1976-12-21 Pierre Fabre S.A. Process for obtaining a plasminogen activator
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
NZ191320A (en) * 1978-09-07 1982-09-14 Beecham Group Ltd In vivo fibrinolytic enzyme having active site blocked by hydrolytically removable group pharmaceutical compositions
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4381346A (en) * 1979-11-13 1983-04-26 Huasin Syed S Isolation of plasminogen activators useful as therapeutic and diagnostic agents
US4390630A (en) * 1980-10-28 1983-06-28 The Regents Of The University Of California Hementin--a fibrinolytic agent

Also Published As

Publication number Publication date
PT74743A (en) 1982-05-01
ES8501797A1 (es) 1984-12-01
AU8237582A (en) 1982-10-28
IL65448A0 (en) 1982-07-30
IL65448A (en) 1985-07-31
PT74743B (en) 1983-11-09
AU548758B2 (en) 1986-01-02
EP0064036B1 (en) 1985-08-21
IT8148332A0 (it) 1981-04-23
EP0064036A1 (en) 1982-11-03
DE3265559D1 (en) 1985-09-26
US4532129A (en) 1985-07-30
NZ200254A (en) 1985-07-12
NO821287L (no) 1982-10-25
JPS57181019A (en) 1982-11-08
US4471053A (en) 1984-09-11
ES511604A0 (es) 1984-12-01
IE820952L (en) 1982-10-23
DK180682A (da) 1982-10-24
IT1170913B (it) 1987-06-03
CA1184138A (en) 1985-03-19
IE53107B1 (en) 1988-06-22
ATE15071T1 (de) 1985-09-15

Similar Documents

Publication Publication Date Title
DE3265559D1 (en) Procedure for producing a vasal fibrinolytic active principle and the enzymatic product so prepared
AU576365B2 (en) Collagen and or fibrinogen as carrier of drugs for their introduction into cellular lesion areas
ES479709A1 (es) Procedimiento para la preparacion de corticoide-17-alcohil- carbonatos.
SE9001124L (sv) Foerfarande vid framstaellning av fluffmassa
HUT42955A (en) Process for production of plasminogene activator compositions of stabilized human-tissue
HUT40804A (en) Process for production of medical preparatives containing n-acetyl neuramin acid
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
DK227282A (da) Anti-thrombotikum baseret paa polysaccharider fremgangsmaade til dets fremstilling og farmaceutiske produkter
SE7602751L (sv) Framstellning av n-acyl-l-metionin
AU524777B2 (en) Isolation of tissue protein ppg.
ZA889699B (en) Use of polysulfated heparins
UY25097A1 (es) Proceso para la produccion de heparina
EP0044343A4 (en) PROTHROMBIN-CONTAINING THERAPEUTIC COMPOSITIONS AND METHOD FOR THE PRODUCTION OF ENZYMATICALLY ACTIVE BLOOD-COUTTERING FACTORS FROM PROTHROMBIN-CONTAINING BLOOD FRACTIONS.
AU6932691A (en) Administration method of antithrombin
AU570574B2 (en) Depolymerase enzymes and treatment of fireblight
HU9204036D0 (en) Anti-coagulant preparatives
ES2176349T3 (es) Proceso de sililacion.
HUT58811A (en) Process for producing new polypeptides
ES551375A1 (es) Procedimiento de obtencion de un producto comprimido para aplicacion oftalmologica local.
EP0231425A3 (en) Use of a solution of alpha-chymotrypsin
SU1197669A1 (ru) Способ лечени нагноительных заболеваний легких
EP0351809A3 (en) Blood anticoagulant
UA15579A (uk) Раhозагоювальhий засіб
UA6689A (uk) Спосіб профілактики афективних розладів